Stop Wasting Time & Money Choosing The Wrong Biosimilar Product
​
​
The Problem
The complex and ever-changing factors that affect the biosimilar landscape can make it challenging for health systems to develop effective strategies for choosing the most profitable biosimilar for each patient.
Amplify Rx offers a solution by partnering with healthcare providers and health systems, providing them with our proprietary software that automates the selection of biosimilars at the patient level, leading to increased efficiency and improved margin.
The Solution
01
Real-time decision support
A tool that helps the authorization team quickly find the best biosimilar product for each patient, considering their insurance and the organization's procurement and reimbursement strategies.
03
Maximized financial opportunities
Enhance the experience for prescribers by avoiding unnecessary notifications about therapies that aren't covered, maximizing financial opportunities.
02
Streamlined authorization process
Boost efficiency by instantly knowing the best covered product for different insurance providers, making the authorization process smoother.
04
Improved payer policy management
Increase reimbursement for biosimilar or reference products by creating transparency into payer policies.
The Challenge:
Inova Case Study
Inova, like most US health systems, needed support keeping up with the frequency of changes within payer polices in the biosimilar space.
​
They were in search of a solution that improved the operational efficiency of their authorization process.
​
They needed a technology that allowed them to maximize financial opportunities in the biosimilar space.
Meet the Team
The founders of Amplify Rx have over 4 decades of combined experience in pharmacy.
